Identification of temozolomide resistance factors in glioblastoma via integrative miRNA/mRNA regulatory network analysis

Lotte Hiddingh, Rajiv S. Raktoe, Judith Jeuken, Esther Hulleman, David P. Noske, Gertjan J.L. Kaspers, William P. Vandertop, Pieter Wesseling, Thomas Wurdinger

Onderzoeksoutput: Bijdrage aan tijdschriftArtikelpeer review

Samenvatting

Drug resistance is a major issue in the treatment of glioblastoma. Almost all glioblastomas are intrinsically resistant to chemotherapeutic temozolomide (TMZ) or develop resistance during treatment. The interaction networks of microRNAs (miRNAs) and mRNAs likely regulate most biological processes and can be employed to better understand complex processes including drug resistance in cancer. In this study, we examined if integrative miRNA/mRNA network analysis using the web-service tool mirConnX could be used to identify drug resistance factors in glioblastoma. We used TMZ-resistant glioblastoma cells and their integrated miRNA/mRNA networks to identify TMZ-sensitizing factors. TMZ resistance was previously induced in glioblastoma cell lines U87, Hs683, and LNZ308. miRNA/mRNA expression profiling of these cells and integration of the profiles using mirConnX resulted in the identification of plant homeodomain (PHD)-like finger 6 (PHF6) as a potential TMZ-sensitizing factor in resistant glioblastoma cells. Analysis of PHF6 expression showed significant upregulation in glioblastoma as compared to normal tissue. Interference with PHF6 expression in three TMZ-resistant subclones significantly enhanced TMZ-induced cell kill in two of these cell lines. Altogether, these results demonstrate that mirConnX is a feasible and useful tool to investigate miRNA/mRNA interactions in TMZ-resistant cells and has potential to identify drug resistance factors in glioblastoma.
Originele taal-2Engels
Pagina's (van-tot)5260
TijdschriftScientific Reports
Volume4
DOI's
StatusGepubliceerd - 11 jun. 2014
Extern gepubliceerdJa

Vingerafdruk

Duik in de onderzoeksthema's van 'Identification of temozolomide resistance factors in glioblastoma via integrative miRNA/mRNA regulatory network analysis'. Samen vormen ze een unieke vingerafdruk.

Citeer dit